Cargando…

Anti-COVID-19 potential of Azadirachta indica (Neem) leaf extract

COVID-19 is caused by infection with the “severe acute respiratory syndrome coronavirus-2″ (i.e., SARS-CoV-2). This is an enveloped virus having a positive sense, single-stranded RNA genome; like the two earlier viruses SARS-CoV and the Middle East respiratory syndrome (MERS) virus. COVID-19 is uniq...

Descripción completa

Detalles Bibliográficos
Autores principales: Eze, Michael O., Ejike, Chukwunonso E.C.C., Ifeonu, Patrick, Udeinya, Iroka J., Udenigwe, Chibuike C., Uzoegwu, Peter N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier B.V. on behalf of African Institute of Mathematical Sciences / Next Einstein Initiative. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8990437/
https://www.ncbi.nlm.nih.gov/pubmed/35434432
http://dx.doi.org/10.1016/j.sciaf.2022.e01184
_version_ 1784683372912574464
author Eze, Michael O.
Ejike, Chukwunonso E.C.C.
Ifeonu, Patrick
Udeinya, Iroka J.
Udenigwe, Chibuike C.
Uzoegwu, Peter N.
author_facet Eze, Michael O.
Ejike, Chukwunonso E.C.C.
Ifeonu, Patrick
Udeinya, Iroka J.
Udenigwe, Chibuike C.
Uzoegwu, Peter N.
author_sort Eze, Michael O.
collection PubMed
description COVID-19 is caused by infection with the “severe acute respiratory syndrome coronavirus-2″ (i.e., SARS-CoV-2). This is an enveloped virus having a positive sense, single-stranded RNA genome; like the two earlier viruses SARS-CoV and the Middle East respiratory syndrome (MERS) virus. COVID-19 is unique in that, in the severe case, it has the propensity to affect multiple organs, leading to multiple organ distress syndrome (MODS), and causing high morbidity and mortality in the extreme case. In addition, comorbidities like age, cardiovascular disease, diabetes and its complications, obesity, are risk factors for severe COVID-19. It turns out that a most plausible, simple, single explanation for this propensity for MODS is the pivotal involvement of the vascular endothelium (VE). This is a consequence of the fact that the VE seamlessly connects all the entire vascular bed in the body, thus linking all the target organs (heart, lungs, kidney, liver, brain) and systems. Infection with SARS-CoV-2 leads to hyper-inflammation yielding uncontrolled production of a mixture of cytokines, chemokines, reactive oxygen species, nitric oxide, oxidative stress, acute phase proteins (e.g., C-reactive protein), and other pro-inflammatory substances. In the extreme case, a cytokine storm is created. Displacement of the virus bound to the VE, and/or inhibition of binding of the virus, would constitute an effective strategy for preventing COVID-19. In this regard, the acetone-water extract of the leaf of the Neem (Azadirachta indica) plant has been known to prevent the adherence of malaria parasitized red blood cells (pRBCs) to VE; prevent cytoadherence of cancer cells in metastasis; and prevent HIV from invading target T lymphocytes. We therefore hypothesize that this Neem leaf acetone-water extract will prevent the binding of SARS-CoV-2 to the VE, and therefore be an effective therapeutic formulation against COVID-19. It is therefore advocated herein that this extract be investigated through rigorous clinical trials for this purpose. It has the advantages of being (i) readily available, and renewable in favor of the populations positioned to benefit from it; (ii) simple to prepare; and (iii) devoid of any detectable toxicity.
format Online
Article
Text
id pubmed-8990437
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher The Authors. Published by Elsevier B.V. on behalf of African Institute of Mathematical Sciences / Next Einstein Initiative.
record_format MEDLINE/PubMed
spelling pubmed-89904372022-04-11 Anti-COVID-19 potential of Azadirachta indica (Neem) leaf extract Eze, Michael O. Ejike, Chukwunonso E.C.C. Ifeonu, Patrick Udeinya, Iroka J. Udenigwe, Chibuike C. Uzoegwu, Peter N. Sci Afr Article COVID-19 is caused by infection with the “severe acute respiratory syndrome coronavirus-2″ (i.e., SARS-CoV-2). This is an enveloped virus having a positive sense, single-stranded RNA genome; like the two earlier viruses SARS-CoV and the Middle East respiratory syndrome (MERS) virus. COVID-19 is unique in that, in the severe case, it has the propensity to affect multiple organs, leading to multiple organ distress syndrome (MODS), and causing high morbidity and mortality in the extreme case. In addition, comorbidities like age, cardiovascular disease, diabetes and its complications, obesity, are risk factors for severe COVID-19. It turns out that a most plausible, simple, single explanation for this propensity for MODS is the pivotal involvement of the vascular endothelium (VE). This is a consequence of the fact that the VE seamlessly connects all the entire vascular bed in the body, thus linking all the target organs (heart, lungs, kidney, liver, brain) and systems. Infection with SARS-CoV-2 leads to hyper-inflammation yielding uncontrolled production of a mixture of cytokines, chemokines, reactive oxygen species, nitric oxide, oxidative stress, acute phase proteins (e.g., C-reactive protein), and other pro-inflammatory substances. In the extreme case, a cytokine storm is created. Displacement of the virus bound to the VE, and/or inhibition of binding of the virus, would constitute an effective strategy for preventing COVID-19. In this regard, the acetone-water extract of the leaf of the Neem (Azadirachta indica) plant has been known to prevent the adherence of malaria parasitized red blood cells (pRBCs) to VE; prevent cytoadherence of cancer cells in metastasis; and prevent HIV from invading target T lymphocytes. We therefore hypothesize that this Neem leaf acetone-water extract will prevent the binding of SARS-CoV-2 to the VE, and therefore be an effective therapeutic formulation against COVID-19. It is therefore advocated herein that this extract be investigated through rigorous clinical trials for this purpose. It has the advantages of being (i) readily available, and renewable in favor of the populations positioned to benefit from it; (ii) simple to prepare; and (iii) devoid of any detectable toxicity. The Authors. Published by Elsevier B.V. on behalf of African Institute of Mathematical Sciences / Next Einstein Initiative. 2022-07 2022-04-08 /pmc/articles/PMC8990437/ /pubmed/35434432 http://dx.doi.org/10.1016/j.sciaf.2022.e01184 Text en © 2022 The Authors. Published by Elsevier B.V. on behalf of African Institute of Mathematical Sciences / Next Einstein Initiative. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Eze, Michael O.
Ejike, Chukwunonso E.C.C.
Ifeonu, Patrick
Udeinya, Iroka J.
Udenigwe, Chibuike C.
Uzoegwu, Peter N.
Anti-COVID-19 potential of Azadirachta indica (Neem) leaf extract
title Anti-COVID-19 potential of Azadirachta indica (Neem) leaf extract
title_full Anti-COVID-19 potential of Azadirachta indica (Neem) leaf extract
title_fullStr Anti-COVID-19 potential of Azadirachta indica (Neem) leaf extract
title_full_unstemmed Anti-COVID-19 potential of Azadirachta indica (Neem) leaf extract
title_short Anti-COVID-19 potential of Azadirachta indica (Neem) leaf extract
title_sort anti-covid-19 potential of azadirachta indica (neem) leaf extract
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8990437/
https://www.ncbi.nlm.nih.gov/pubmed/35434432
http://dx.doi.org/10.1016/j.sciaf.2022.e01184
work_keys_str_mv AT ezemichaelo anticovid19potentialofazadirachtaindicaneemleafextract
AT ejikechukwunonsoecc anticovid19potentialofazadirachtaindicaneemleafextract
AT ifeonupatrick anticovid19potentialofazadirachtaindicaneemleafextract
AT udeinyairokaj anticovid19potentialofazadirachtaindicaneemleafextract
AT udenigwechibuikec anticovid19potentialofazadirachtaindicaneemleafextract
AT uzoegwupetern anticovid19potentialofazadirachtaindicaneemleafextract